Answer
Eribulin should be avoided in patients with congenital long QT syndrome because QT prolongation was observed on Day 8 in an uncontrolled, open-label ECG study of 26 patients, independently of eribulin concentration.
Sources for this answer
- Eribulin Baxter 0.44 mg/mL solution for injectionBaxter Healthcare Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 2Document updated
Sources checked